Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

ClinicalTrials.gov ID: NCT07335510

Public ClinicalTrials.gov record NCT07335510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 1:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Impact of Barostimulation in Cardiac Hemodynamics and Clinical Outcomes Through Use of the Barostim™ CVRx Device

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerated doses of guideline directed medical and device therapies. The study aims to assess how therapy using this device affects heart function, symptoms, and exercise capacity, with particular focus on how the device affects blood flow and heart pressures during exercise. Information from this study may help inform patient selection and device management in patients with heart failure.

Study identification

NCT ID
NCT07335510
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Columbia University
Other
Enrollment
58 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 29, 2026
Primary completion
Nov 30, 2027
Completion
Feb 29, 2028
Last update posted
Jun 28, 2026

2026 – 2028

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
University of California San Francisco Health San Francisco California 94143 Not yet recruiting
MedStar Health Washington D.C. District of Columbia 20010 Not yet recruiting
University of Chicago Medical Center Chicago Illinois 15212 Not yet recruiting
Weill Cornell Medicine New York New York 10021 Not yet recruiting
Columbia University Irving Medical Center New York New York 10032 Recruiting
Montefiore Medical Center New York New York 10461 Not yet recruiting
Medical University of South Carolina Health Charleston South Carolina 29425 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07335510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 28, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07335510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →